CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) shot up 1.3% on Friday. The company traded as high as C$4.76 and last traded at C$4.76. 102 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 3,122 shares. The stock had previously closed at C$4.70.
CSPC Pharmaceutical Group Stock Up 1.3%
The business has a fifty day moving average price of C$4.52 and a 200 day moving average price of C$4.27.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company engaged in the research, development, manufacture and sale of medicines and pharmaceutical ingredients. The company offers prescription and over-the-counter products across several therapeutic areas, including cardiovascular and cerebrovascular conditions, oncology, central nervous system disorders, infectious diseases and gastrointestinal conditions.
Its product portfolio includes innovative medicines, generic drugs, traditional Chinese medicines and active pharmaceutical ingredients.
Read More
- Five stocks we like better than CSPC Pharmaceutical Group
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
